163 related articles for article (PubMed ID: 32044512)
21. 1 Versus 2-cm Excision Margins for pT2-pT4 Primary Cutaneous Melanoma (MelMarT): A Feasibility Study.
Moncrieff MD; Gyorki D; Saw R; Spillane AJ; Thompson JF; Peach H; Oudit D; Geh J; Dziewulski P; Wilson E; Matteucci P; Pritchard-Jones R; Olofsson Bagge R; Wright FC; Crampton N; Cassell O; Jallali N; Berger A; Kelly J; Hamilton S; Durrani A; Lo S; Paton E; Henderson MA
Ann Surg Oncol; 2018 Sep; 25(9):2541-2549. PubMed ID: 29850955
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of Staged Excision With Permanent Section Margin Control for Cutaneous Head and Neck Melanoma.
Moyer JS; Rudy S; Boonstra PS; Kraft C; Chinn SB; Baker SR; Schwartz JL; Bichakjian CK; Fullen D; Durham AB; Lowe L; Johnson TM
JAMA Dermatol; 2017 Mar; 153(3):282-288. PubMed ID: 28002553
[TBL] [Abstract][Full Text] [Related]
23. Sentinel lymph node biopsy in cutaneous melanoma of the head and neck using the indocyanine green SPY Elite system.
Vahabzadeh-Hagh AM; Blackwell KE; Abemayor E; St John MA
Am J Otolaryngol; 2018; 39(5):485-488. PubMed ID: 29803536
[TBL] [Abstract][Full Text] [Related]
24. A population-based assessment of melanoma: Does treatment in a regional cancer center make a difference?
Rivard J; Kostaras X; Shea-Budgell M; Chin-Lenn L; Quan ML; McKinnon JG
J Surg Oncol; 2015 Aug; 112(2):173-8. PubMed ID: 26445222
[TBL] [Abstract][Full Text] [Related]
25. Population-based assessment of surgical treatment trends for patients with melanoma in the era of sentinel lymph node biopsy.
Cormier JN; Xing Y; Ding M; Lee JE; Mansfield PF; Gershenwald JE; Ross MI; Du XL
J Clin Oncol; 2005 Sep; 23(25):6054-62. PubMed ID: 16135473
[TBL] [Abstract][Full Text] [Related]
26. The management of primary cutaneous melanoma in Victoria in 1996 and 2000.
Kelly JW; Henderson MA; Thursfield VJ; Slavin J; Ainslie J; Giles GG
Med J Aust; 2007 Nov; 187(9):511-4. PubMed ID: 17979616
[TBL] [Abstract][Full Text] [Related]
27. Impact of Biopsy Modality on the Management of Cutaneous Melanoma of the Head and Neck.
Namin AW; Zitsch RP
Otolaryngol Head Neck Surg; 2018 Mar; 158(3):473-478. PubMed ID: 29110565
[TBL] [Abstract][Full Text] [Related]
28. Prospective study of pigmented lesions managed by shave excision with no deep margin transection of melanomas.
Shao E; Blake T; Po-Chao F; Pool L; Carew B; Yong-Gee S; Wheller L; De'Ambrosis B; Muir J
Australas J Dermatol; 2020 Aug; 61(3):269-272. PubMed ID: 32419172
[TBL] [Abstract][Full Text] [Related]
29. Suboptimal Compliance With National Comprehensive Cancer Network Melanoma Guidelines: Who Is at Risk?
Blakely AM; Comissiong DS; Vezeridis MP; Miner TJ
Am J Clin Oncol; 2018 Aug; 41(8):754-759. PubMed ID: 28121641
[TBL] [Abstract][Full Text] [Related]
30. Thin Melanoma: A Generic Term Including Four Histological Subtypes of Cutaneous Melanoma.
Roncati L; Pusiol T; Piscioli F
Acta Dermatovenerol Croat; 2016 Dec; 24(4):169-174. PubMed ID: 28128089
[TBL] [Abstract][Full Text] [Related]
31. 'Primum non nocere': how harmless is routine wide local excision for AJCC stage IA melanoma?
Lau KL; Bradish T; Rannan-Eliya S
Ann R Coll Surg Engl; 2020 Sep; 102(7):483-487. PubMed ID: 32233852
[TBL] [Abstract][Full Text] [Related]
32. Margins of excision for cutaneous melanoma of the eyelid skin: the Collaborative Eyelid Skin Melanoma Group Report.
Esmaeli B; Youssef A; Naderi A; Ahmadi MA; Meyer DR; McNab A;
Ophthalmic Plast Reconstr Surg; 2003 Mar; 19(2):96-101. PubMed ID: 12644753
[TBL] [Abstract][Full Text] [Related]
33. Workup and staging of malignant melanoma.
Kauffmann RM; Chen SL
Surg Clin North Am; 2014 Oct; 94(5):963-72, vii. PubMed ID: 25245961
[TBL] [Abstract][Full Text] [Related]
34. Pathology of melanocytic lesions: new, controversial, and clinically important issues.
Scolyer RA; Thompson JF; Stretch JR; Sharma R; McCarthy SW
J Surg Oncol; 2004 Jul; 86(4):200-11. PubMed ID: 15221927
[TBL] [Abstract][Full Text] [Related]
35. The effect of the AJCC 7th edition change in T1 melanoma substaging on national utilization and outcomes of sentinel lymph node biopsy for thin melanoma.
Hieken TJ; Grotz TE; Comfere NI; Inselman JW; Habermann EB
Melanoma Res; 2015 Apr; 25(2):157-63. PubMed ID: 25647736
[TBL] [Abstract][Full Text] [Related]
36. Discordance of histopathologic parameters in cutaneous melanoma: Clinical implications.
Patrawala S; Maley A; Greskovich C; Stuart L; Parker D; Swerlick R; Stoff B
J Am Acad Dermatol; 2016 Jan; 74(1):75-80. PubMed ID: 26514601
[TBL] [Abstract][Full Text] [Related]
37. Interobserver variability of histopathological prognostic parameters in cutaneous malignant melanoma: impact on patient management.
Eriksson H; Frohm-Nilsson M; Hedblad MA; Hellborg H; Kanter-Lewensohn L; Krawiec K; Lundh Rozell B; Månsson-Brahme E; Hansson J
Acta Derm Venereol; 2013 Jul; 93(4):411-6. PubMed ID: 23306667
[TBL] [Abstract][Full Text] [Related]
38. Tumor mitotic rate added to the equation: melanoma prognostic factors changed? : a single-institution database study on the prognostic value of tumor mitotic rate for sentinel lymph node status and survival of cutaneous melanoma patients.
Speijers MJ; Bastiaannet E; Sloot S; Suurmeijer AJ; Hoekstra HJ
Ann Surg Oncol; 2015 Sep; 22(9):2978-87. PubMed ID: 25605514
[TBL] [Abstract][Full Text] [Related]
39. Surgical management of melanoma.
Burke EE; Sondak VK
Semin Cutan Med Surg; 2018 Jun; 37(2):101-108. PubMed ID: 30040086
[TBL] [Abstract][Full Text] [Related]
40. Impact of Shave Biopsy on Diagnosis and Management of Cutaneous Melanoma: A Systematic Review and Meta-Analysis.
Ahmadi O; Das M; Hajarizadeh B; Mathy JA
Ann Surg Oncol; 2021 Oct; 28(11):6168-6176. PubMed ID: 33782802
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]